Director, RaaS Research Group, Research as a Service (RaaS)

RaaS Research Group (RaaS)

Director, RaaS Research Group

Insightful Financial Models and Research Analysis

Research as a Service (RaaS)

Connect to the right investors through smart and insightful financial models and research analysis.

Equity Bottom-Up

<ul><li>Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM (Tocopheryl Phosphate Mixture).</li><li>AVE is currently focusing its efforts on a CBD (cannabidiol) soft-gel capsule for treating insomnia.</li><li>AVE is currently undergoing a pivotal Phase III clinical trial of the drug with the potential to be the first over-the-counter (OTC) CBD sleep aid approved by Australia’s Therapeutic Goods Administration (TGA), meaning the drug could be purchased directly and easily at a pharmacy without any prescription required from a doctor.</li></ul>

Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM (Tocopheryl Phosphate Mixture).AVE is currently focusing its efforts on a CBD (cannabidiol) soft-gel capsule for treating insomnia.AVE is currently undergoing a pivotal Phase III clinical trial of the drug with the potential to be the first over-the-counter (OTC) CBD sleep aid approved by Australia’s Therapeutic Goods Administration (TGA), meaning the drug could be purchased directly and easily at a pharmacy without any prescription required from a doctor.

Avecho Biotechnology Ltd - Waking the sleeping giant

Australia

Avecho Biotechnology Limited operates as a Melbourne-based biotechnology company. The Company focused on the development, sale, and licensing of pharmaceutical products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Phosphagenics Ltd (AVE AU)

Avecho Biotechnology Ltd - Waking the sleeping giant

Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM...

Research as a Service (RaaS)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)